Biotech · Private company
Sound Pharmaceuticals, Incorporated
Track this companyFree. Adds Sound Pharmaceuticals, Incorporated to your Dealase workspace and tells you when its record changes.
Clinical trials113 recruiting or active
Pipeline programs18From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline18
- EbselenPhase 3 · Meniere DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- EbselenPhase 3 · Meniere's DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- 200mg SPI-1005 BIDPhase 2 · Meniere's DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- 400mg SPI-1005 BIDPhase 2 · Meniere's DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- EbselenPhase 2 · Covid19ClinicalTrials.gov · fetched Nov 12, 2026
- EbselenPhase 2 · Hearing LossClinicalTrials.gov · fetched Nov 12, 2026
- SPI-1005Phase 2 · Meniere's DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- SPI-1005 200mgPhase 2 · Noise Induced Hearing LossClinicalTrials.gov · fetched Nov 12, 2026
- SPI-1005 400mgPhase 2 · Noise Induced Hearing LossClinicalTrials.gov · fetched Nov 12, 2026
- SPI-1005 Ebselen 200mg Capsule x1Phase 2 · OtotoxicityClinicalTrials.gov · fetched Nov 12, 2026
- SPI-1005 Ebselen 200mg Capsule x2Phase 2 · OtotoxicityClinicalTrials.gov · fetched Nov 12, 2026
- SPI-1005 Ebselen 200mg Capsule x3Phase 2 · OtotoxicityClinicalTrials.gov · fetched Nov 12, 2026
- SPI-1005 High dosePhase 2 · Temporary Auditory Threshold ShiftClinicalTrials.gov · fetched Nov 12, 2026
- SPI-1005 High DosePhase 2 · Lung CancerClinicalTrials.gov · fetched Nov 12, 2026
- SPI-1005 Low dosePhase 2 · Temporary Auditory Threshold ShiftClinicalTrials.gov · fetched Nov 12, 2026
- SPI-1005 Low DosePhase 2 · Lung CancerClinicalTrials.gov · fetched Nov 12, 2026
- SPI-1005 Middle dosePhase 2 · Temporary Auditory Threshold ShiftClinicalTrials.gov · fetched Nov 12, 2026
- SPI-1005 Middle DosePhase 2 · Lung CancerClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials11
- SPI-1005 in Adults Receiving Cochlear ImplantPHASE2 · RECRUITING · started Dec 1, 2026ClinicalTrials.gov NCT06340633 · fetched Nov 12, 2026
- A Phase 2b Study of SPI-1005 to Prevent Acute Noise Induced Hearing LossPHASE2 · WITHDRAWN · started Jun 1, 2026ClinicalTrials.gov NCT02779192 · fetched Nov 12, 2026
- SPI-1005 for Prevention and Treatment of Chemotherapy Induced Hearing LossPHASE2 · WITHDRAWN · started Jun 1, 2026ClinicalTrials.gov NCT01451853 · fetched Nov 12, 2026
- SPI-1005 for the Treatment of Meniere's Disease (Open Label)PHASE3 · ACTIVE_NOT_RECRUITING · started Oct 29, 2025ClinicalTrials.gov NCT06859788 · fetched Nov 12, 2026
- SPI-1005 for the Treatment of Meniere's DiseasePHASE3 · COMPLETED · started Aug 2, 2022ClinicalTrials.gov NCT04677972 · fetched Nov 12, 2026
- SPI-1005 Treatment in Moderate COVID-19 PatientsPHASE2 · ENROLLING_BY_INVITATION · started Oct 12, 2021ClinicalTrials.gov NCT04484025 · fetched Nov 12, 2026
- SPI-1005 Treatment in Severe COVID-19 PatientsPHASE2 · COMPLETED · started Aug 27, 2021ClinicalTrials.gov NCT04483973 · fetched Nov 12, 2026
- SPI-1005 for the Treatment of Patients With Meniere's DiseasePHASE2 · COMPLETED · started Sep 28, 2017ClinicalTrials.gov NCT03325790 · fetched Nov 12, 2026
- SPI-1005 for Prevention and Treatment of Tobramycin Induced OtotoxicityPHASE2 · COMPLETED · started Jul 21, 2017ClinicalTrials.gov NCT02819856 · fetched Nov 12, 2026
- Study to Evaluate SPI-1005 in Adults With Meniere's DiseasePHASE1_PHASE2 · COMPLETED · started Dec 1, 2015ClinicalTrials.gov NCT02603081 · fetched Nov 12, 2026
- Otoprotection With SPI-1005 for Prevention of Temporary Auditory Threshold ShiftPHASE2 · COMPLETED · started Sep 1, 2011ClinicalTrials.gov NCT01444846 · fetched Nov 12, 2026